Transcend Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Transcend Capital Advisors, LLC

  • $1.35 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023
BUY
$705.89 - $766.39 $80,471 - $87,368
114 Added 37.5%
418 $0
Q3 2022

Oct 17, 2022
BUY
$573.97 - $724.32 $174,486 - $220,193
304 New
304 $209,000
Q2 2020

Aug 05, 2020
SELL
$493.32 - $643.92 $230,380 - $300,710
-467 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$336.18 - $494.43 $156,996 - $230,898
467 New
467 $239,000

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email